Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Cash Flow from Operations

Adverum Biotechnlgs Cash Flow from Operations Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Cash Flow from Operations from 2013 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending June 06, 2020 was $-17m a 43.63% decrease of -7m year over year
  • Adverum Biotechnlgs Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-55m a 14.25% decrease of -8m year over year
  • Adverum Biotechnlgs Annual Cash Flow from Operations for 2019 was $-49m a -9.75% increase of 5m from 2018
  • Adverum Biotechnlgs Annual Cash Flow from Operations for 2018 was $-54m a 15.83% decrease of -9m from 2017
  • Adverum Biotechnlgs Annual Cash Flow from Operations for 2017 was $-45m a 15.53% decrease of -7m from 2016
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-26m a 70.14% decrease of -18m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Cash Flow from Operations Data

06/2020$-17m
03/2020$-14m
12/2019$-15m
09/2019$-10m
06/2019$-12m
03/2019$-13m
12/2018$-13m
09/2018$-17m
06/2018$-11m
03/2018$-13m

Annual ADVM Cash Flow from Operations Data

2019$-49m
2018$-54m
2017$-45m
2016$-38m
2015$-35m
2014$-6m
2013$-2m
2012$-1m